Selection and validation of hybridoma clones for optimal signal-to-noise ratio among a wide range of tissues.
Detailed profiling of antibody staining pattern in high range of tissues entities.
Beta-testing and validation by different independent labs.
Our focus is on new antibody clones that are extensively validated for sensitivity, specificity and – if possible – clinical significance on a high range of human tissues. We believe that this „ULTRA-validation“ approach results in new antibodies that will make both diagnostic and clinical differences.
To face the high demand for better antibody clones to be used as biomarkers to phenotype tumors, we continue to develop optimized clones with our partners.